Ozempic (semaglutide) is a once-weekly injectable GLP-1 receptor agonist originally approved for type 2 diabetes
Patients receive thorough evaluations, ongoing monitoring, and lifestyle guidance to support sustainable weight loss using FDA-cleared oral semaglutide as part of a comprehensive approach
Exposing transdermal patches to external heat sources (heating pads, saunas, hot tubs, prolonged sun exposure) can significantly increase drug absorption and potentially cause overdose
If medication is stopped without maintaining lifestyle changes, many people regain some of the lost weight
they are advanced patches fitted with hundreds of microscopic, dissolvable needles made of the drug itself or other biocompatible materials
[3] The availability of an oral formulation offers an alternative for patients who prefer or require an oral medication over injections